Aura Biosciences, Inc. financial data

Symbol
AURA on Nasdaq
Location
80 Guest Street, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.07K % -38.6%
Debt-to-equity 19.8 % +40.4%
Return On Equity -69.7 % -67.6%
Return On Assets -58.2 % -59.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.5M shares +27.1%
Common Stock, Shares, Outstanding 63M shares +26.5%
Entity Public Float 192M USD -14.6%
Weighted Average Number of Shares Outstanding, Basic 65.9M shares +32.8%
Weighted Average Number of Shares Outstanding, Diluted 65.9M shares +32.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 90.7M USD +27.4%
General and Administrative Expense 22.6M USD +3.58%
Operating Income (Loss) -113M USD -21.8%
Nonoperating Income (Expense) 7.01M USD -30.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -106M USD -28.1%
Income Tax Expense (Benefit) 26K USD -39.5%
Net Income (Loss) Attributable to Parent -106M USD -27.9%
Earnings Per Share, Basic -1 USD/shares -11.5%
Earnings Per Share, Diluted -1 USD/shares -11.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.6M USD +87.2%
Cash, Cash Equivalents, and Short-term Investments 149M USD +33.7%
Other Assets, Current 2.59M USD -24.4%
Assets, Current 170M USD -7.28%
Property, Plant and Equipment, Net 2.63M USD -20.9%
Operating Lease, Right-of-Use Asset 16.2M USD -8.53%
Other Assets, Noncurrent 277K USD +1159%
Assets 190M USD -7.46%
Accounts Payable, Current 1.89M USD -5.17%
Liabilities, Current 18.8M USD +27.9%
Operating Lease, Liability, Noncurrent 14.5M USD -8.92%
Liabilities 33.4M USD +8.75%
Accumulated Other Comprehensive Income (Loss), Net of Tax 69K USD -88.6%
Retained Earnings (Accumulated Deficit) -455M USD -30.6%
Stockholders' Equity Attributable to Parent 157M USD -10.3%
Liabilities and Equity 190M USD -7.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.4M USD +4.49%
Net Cash Provided by (Used in) Financing Activities 96K USD -62.1%
Net Cash Provided by (Used in) Investing Activities 29.8M USD +217%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 63M shares +26.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8M USD +82.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.3M USD +84.6%
Deferred Tax Assets, Valuation Allowance 106M USD +29.2%
Deferred Tax Assets, Gross 111M USD +27.4%
Operating Lease, Liability 17.8M USD -6.97%
Depreciation 1.21M USD +2.98%
Payments to Acquire Property, Plant, and Equipment 187K USD +113%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -107M USD -29.7%
Lessee, Operating Lease, Liability, to be Paid 25.2M USD -11.5%
Property, Plant and Equipment, Gross 9.47M USD +1.94%
Operating Lease, Liability, Current 3.22M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.51M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.41M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.43M USD -20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.61M USD +2.97%
Deferred Tax Assets, Operating Loss Carryforwards 55.8M USD +21.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.72M USD +2.88%
Operating Lease, Payments 816K USD +8.66%
Additional Paid in Capital 611M USD +17%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 14M USD +22.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%